Navigation Links
QPS Expands Into Toxicology Services With Acquisition of the Preclinical Unit of DCB Taiwan
Date:2/14/2011

NEWARK, Del. and TAIPEI, Taiwan, Feb. 14, 2011 /PRNewswire/ -- QPS Holdings, LLC, a leading full-service GLP/GCP-compliant contract research organization providing testing services to support preclinical and clinical research and development, announced the acquisition of the Center of Toxicology and Preclinical Sciences (CTPS) from Taiwan's Development Center for Biotechnology (DCB). CTPS, located in Taipei, will become a division of QPS-Taiwan.

QPS is a global CRO supporting drug discovery and development since 1995. Its five areas of expertise include: Preclinical DMPK/Toxicology, Bioanalytical, Translational Medicine, Early Stage Clinical and Late Stage Clinical Research.

CTPS is an ISO/IEC 17025 certified, GLP compliant (Taiwan DOH, OECD) and AAALAC accredited facility specializing in general nonclinical toxicity and safety testing, genetic toxicology, reproductive toxicology, immunotoxicity testing, biocompatibility testing, and DMPK studies. The center for toxicology and preclinical services covers 5600 square meters (60,000 square feet) and includes: seven laboratories, three culture rooms, a quality assurance unit, archives, and two floors of animal housing.

In the past 12 years, DCB has conducted over 890 studies for local and international clients, including 17 projects for US IND submissions, 18 projects for Taiwan IND submissions or clinical trials, and 2 products seeking Taiwan NDA approval.

"The biotech industry in the Asia Pacific region is expanding rapidly," says Vincent Yen, President and CEO of QPS-Taiwan. "With the addition of a well known toxicology unit to our established bioanalytical and pharmacokinetic expertise, QPS can now provide a one-stop solution to the increasing local and international demand for high quality preclinical services. Along with our recent acquisitions in Europe and India, this represents another step in building world-class global capabilities."

Dr. Walter Bee, QPS' new VP and Head of Global Safety Assessment and Regulatory Affairs, brings to the table over 20 years of CRO and Pharma/Biotech experience in Preclinical Development. He notes, "I'm thrilled to be joining an organization that is as highly regarded and dynamic as QPS. The addition of the DCB toxicology unit, a top-notch toxicology facility with an admirable track record for providing first-rate, exacting service, definitely enhances QPS' offerings for its clients worldwide."

About QPS

QPS provides GLP/GCP-compliant preclinical and clinical research services to pharmaceutical and biotechnology clients worldwide in the areas of Bioanalysis, Drug Metabolism and Pharmacokinetics, Translational Medicine, and Clinical Research. Founded by Dr. Ben Chien in 1995, QPS has Bioanalysis and Preclinical testing facilities at its Newark, DE headquarters; and facilities in Groningen, the Netherlands; Taipei, Taiwan; and Hyderabad, India. Early-phase clinical facilities are located in Springfield, MO; Taipei, Taiwan; Groningen, the Netherlands; and Hyderabad, India. Business development offices are maintained in the US, Europe, and Asia.

About DCB

The Development Center for Biotechnology (DCB) of Taiwan was established in 1984 with support from the Department of Industrial Technology (DOIT) and the Ministry of Economic Affairs (MOEA). DCB's main mission was to help shape and develop Taiwan's biotechnology industry through R&D, infrastructure-building and training programs. DCB played the crucial role of facilitator in promoting synergy among governmental, academic and industrial efforts and served as an important bridge connecting Taiwan's biotech industry with the world.

www.qps-usa.com


'/>"/>
SOURCE QPS Holdings, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. MicuRx Pharmaceuticals Selects Next-Generation Antibiotic Candidate Targeting MRSA and Expands Operation in China
2. Hoya Vision Care Expands in Czech Republic
3. Oridion Expands its OEM Partnerships - New Agreement with Spacelabs Healthcare
4. InVitria Expands Sales Team
5. Enerkem Expands Executive Management Team
6. PSKW Expands Its Lawsuit Against McKesson to Seek Assignment of McKessons Patent Application
7. Supelco(R) Expands Ascentis(R) Express HPLC Columns Line for High-Speed and High-Efficiency Separations
8. BioElectronics Corp Aggressively Expands Sales into Middle East
9. Quintiles Expands Base for Growing Asia-Pacific Operations
10. CryoLife Expands Distribution of Hemostase MPH(R) to France through Laboratoire Gamida
11. AIT Laboratories Expands Pharma Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)...  Renova™ Therapeutics, a biotechnology company developing gene ... chronic diseases, announced that Catherine Bovenizer , ... Officer (CFO), effective today. Ms. Bovenizer ... in financial management for a variety of public ... recently, Ms. Bovenizer was the Vice President of ...
(Date:12/5/2016)... Research and Markets has announced the ... Technologies, Markets and Companies" to their offering. ... , , ... human genome variations, development of sequencing technologies, and their applications. ... companies developing them. Various applications of sequencing are described including ...
(Date:12/4/2016)... DIEGO , Dec. 3, 2016  In five ... of Hematology (ASH) Annual Meeting and Exposition in ... biomedical engineering methods to improve the delivery of life-saving ... These new methods are designed to carry therapies directly ... needed most, which could provide a substantial advantage over ...
(Date:12/2/2016)... Dec. 2, 2016  The Multiple Myeloma Research Foundation ... MMRF CoMMpass Study SM —the largest and most comprehensive ... in multiple myeloma—will be presented at the 58 th ... Exposition in San Diego from ... treatment strategies, as well as identify pathways and targets ...
Breaking Biology Technology:
(Date:11/29/2016)... Nearly one billion matches per second with DERMALOG,s high-speed AFIS    ... ... DERMALOG is Germany's largest Multi-Biometric supplier: The company's ... Systems) ... largest Multi-Biometric supplier: The company's Fingerprint Identification System is part of an ...
(Date:11/22/2016)... -- According to the new market research report "Biometric System ... Voice), Multi-Factor), Component (Hardware and Software), Function (Contact and Non-contact), Application, and ... expected to grow from USD 10.74 Billion in 2015 to reach USD ... 2022. Continue Reading ... ...
(Date:11/19/2016)... 18, 2016 Securus Technologies, a leading provider ... safety, investigation, corrections and monitoring, announced today that it ... to have an independent technology judge determine who has ... high tech/sophisticated telephone calling platform, and the best customer ... do most of what we do – which clearly ...
Breaking Biology News(10 mins):